Research Infrastructure Core
研究基础设施核心
基本信息
- 批准号:10361203
- 负责人:
- 金额:$ 50.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAntineoplastic AgentsAreaBehavioral ResearchBiomedical ResearchBiotechnologyCancer BiologyCollaborationsCommunitiesCore FacilityDataDevelopmentDrug Delivery SystemsEducational workshopEpigenetic ProcessExtramural ActivitiesFloridaFlow CytometryFundingGoalsHealth Disparities ResearchImageInfrastructureJournalsKnowledgeMethodologyMissionNational Institute on Minority Health and Health DisparitiesPilot ProjectsProteomicsPublishingResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResource SharingResourcesRuralServicesTeacher Professional DevelopmentTechniquesTrainingUnited States National Institutes of HealthUniversitiesWritingcytokinedata managementdrug discoveryethnic minorityexperiencegraduate studenthealth disparityhigh throughput screeningindexinginfrastructure developmentinnovationinnovative technologiesinvestigator trainingknowledge basemedically underserved populationminority scientistmolecular modelingnew technologyprogramsracial minorityresearch and developmentskillssuccesstraining opportunity
项目摘要
Project Summary:
The long-term goal of the Research Infrastructure Core (RIC) is to support, strengthen and expand
biomedical and behavioral research projects at Florida A&M University (FAMU). Over the past three
decades, tremendous success was achieved by FAMU PIs through the active support of the research
infrastructure component of the RCMI Program. FAMU researchers relied on the services provided such
as using key instrumental analysis and research personnel to gather data that were used to write NIH
proposals, develop and sustain funded projects, publish in refereed and indexed scientific journals, as
well as train graduate students successfully. There is a critical need now to invigorate these support
strategies to continue strengthening biomedical and behavioral research activities on campus. The focus
of the FAMU RCMI U54 Research Infrastructure Core will be on promoting innovative technologies that
support the proposed RCMI research projects, pilot projects, and other FAMU biomedical and behavioral
research initiatives that address health disparities experienced by racial and ethnic minorities, the rural
and urban poor and other medically underserved populations. The RIC will 1) provide state-of-the-art
analytical facilities including Proteomics, Flow Cytometry and Imaging, High Throughput Screening
(HTS), NMR, Molecular Modeling Techniques, Cytokine, Microarray and Epigenetics Analysis and Data
Management; 2) enhance and develop research skills and capabilities in drug discovery and
biotechnology by providing new technologies, training of faculty and other researchers in the use of the
facilities of the core; and 3) promote and develop knowledge by providing workshops, seminars and
short courses in drug discovery and biotechnology research applications to enhance research
proficiency. Supporting the infrastructure core is significant because it promotes meaningful
collaborations, allows sharing of resources and provides developmental and training opportunities for
minority scientists. In addition, the proposed Research Infrastructure Core is relevant to the NIH/NIMHD
mission pertaining to the development of the research infrastructure and training of investigators to
become more successful in obtaining competitive extramural support in biomedical and behavioral
research.
项目概要:
研究基础设施核心(RIC)的长期目标是支持、加强和扩大
佛罗里达农工大学(FAMU)的生物医学和行为研究项目。过去三
几十年来,FAMU PI通过对研究的积极支持取得了巨大的成功,
RCMI计划的基础设施组成部分。FAMU的研究人员依赖于提供的服务,
使用关键的仪器分析和研究人员来收集用于编写NIH的数据
建议,开发和维持资助项目,在经过评审和索引的科学期刊上发表,
成功培养研究生。现在迫切需要加强这些支持
继续加强校园生物医学和行为研究活动的战略。重点
FAMU RCMI U 54研究基础设施核心将促进创新技术,
支持拟议的RCMI研究项目,试点项目和其他FAMU生物医学和行为
针对少数种族和族裔、农村地区和其他少数民族在健康方面存在的差异开展的研究举措,
以及城市贫困人口和其他医疗服务不足的人群。RIC将1)提供最先进的
分析设施,包括蛋白质组学、流式细胞术和成像、高通量筛选
(HTS)核磁共振,分子建模技术,细胞因子,微阵列和表观遗传学分析和数据
管理; 2)加强和发展药物发现的研究技能和能力,
通过提供新技术,培训教师和其他研究人员使用生物技术,
核心设施;以及3)通过举办讲习班、研讨会和
药物发现和生物技术研究应用短期课程,以加强研究
熟练程度。支持基础设施核心非常重要,因为它可以促进有意义的
合作,允许共享资源,并为以下人员提供发展和培训机会:
少数民族科学家此外,拟议的研究基础设施核心与NIH/NIMHD相关
与发展研究基础设施和培训调查人员有关的使命,
在获得生物医学和行为学方面有竞争力的校外支持方面更加成功
research.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Moore其他文献
Timothy Moore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Moore', 18)}}的其他基金
Development of novel detection and prediction algorithms for Microcystis blooms
开发微囊藻水华的新型检测和预测算法
- 批准号:
8387923 - 财政年份:2012
- 资助金额:
$ 50.25万 - 项目类别:
Development of novel detection and prediction algorithms for Microcystis blooms
开发微囊藻水华的新型检测和预测算法
- 批准号:
8554363 - 财政年份:2012
- 资助金额:
$ 50.25万 - 项目类别:
Development of novel detection and prediction algorithms for Microcystis blooms
开发微囊藻水华的新型检测和预测算法
- 批准号:
8705519 - 财政年份:2012
- 资助金额:
$ 50.25万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 50.25万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 50.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 50.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 50.25万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 50.25万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 50.25万 - 项目类别:














{{item.name}}会员




